FindTrial
Sign In

Virtual Reality in Individuals with Fibromyalgia and Chronic Pain

Effects of immersive virtual reality-based exercise on pain, kinesiophobia, and catastrophizing in people with fibromyalgia and chronic pain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-926x38d
Enrollment
Unknown
Registered
2024-09-12
Start date
2024-09-30
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Interventions

A longitudinal quasi-experimental study with repeated measures will be conducted, involving two comparison groups and a single-blind design. Participants will be recruited through non-probabilistic co

Sponsors

Universidad San Sebastián
Lead Sponsor
Universidad San Sebastián
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Men and women; age 18 years or older; diagnosed with fibromyalgia (American College of Rheumatology 2016 criteria) or chronic pain; not currently participating in another rehabilitation program

Exclusion criteria

Exclusion criteria: Pregnancy or breastfeeding; pain of oncological origin; uncontrolled metabolic disorder; individuals presenting simultaneously with fibromyalgia and other chronic pain from a cause other than fibromyalgia; individuals with any physical or psychological condition that limits communication with the research team or the full application of the intervention protocol

Design outcomes

Primary

MeasureTime frame
Evaluate the progression of pain intensity measured using the Numeric Rating Scale (NRS) at the beginning and end of the study;Evaluate the progression of pressure pain thresholds in the upper trapezius, hand, lumbar spine, and knee measured using pressure algometry at the beginning and end of the study;Evaluate the progression of catastrophizing measured using the Pain Catastrophizing Scale (PCS) at the beginning and end of the study;Evaluate the progression of kinesiophobia measured using the Tampa Scale of Kinesiophobia (TSK-11) at the beginning and end of the study—

Secondary

MeasureTime frame
Evaluate the progression of hypervigilance measured using the Pain Vigilance and Awareness Questionnaire (PVAQ-9) at the beginning and end of the study;Evaluate the progression of pain interference measured using the Brief Pain Inventory, Spanish Form (BPI-SF) at the beginning and end of the study—

Countries

Chile

Contacts

Public ContactClaudio Carvajal-Parodi

Universidad San Sebastián

claudio.carvajal@uss.cl+56(41)2487240

Outcome results

None listed

Source: REBEC (via WHO ICTRP)